PMEL and melanoma: A key diagnostic challenge arises from the complete or partial loss of expression of conventional melanocytic markers, including S100 protein, SRY-Box transcription factor 10 (SOX10), melanoma antigen A (Melan-A), and human melanoma black-45 (HMB-45).